down arrow

Solara Active

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE624Z01016
  • NSEID: SOLARA
  • BSEID: 541540
INR
511.70
22.05 (4.5%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 29.87 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

496.85528.90

52 Week

366.95885.95
Valuation
Technical
Day's Volume

CASH

29.87 k (-57.23%) Volume

Shareholding (Dec 2024)

FII

14.67%

Held by 62 FIIs

DII

3.19%

Held by 2 DIIs

Promoter

37.23%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with a -17.14% CAGR growth in Operating Profits over the last 5 years

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.03 times
  • The company has been able to generate a Return on Equity (avg) of 4.58% signifying low profitability per unit of shareholders funds
2

Stock is technically in a Bearish range

3

With ROCE of -7.8, it has a Very Expensive valuation with a 1.4 Enterprise value to Capital Employed

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 1,845 Cr (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.77

stock-summary
Return on Equity

-32.34%

stock-summary
Price to Book

1.63

Revenue and Profits (1 Year):
Net Sales:
300 Cr
(Quarterly Results - Dec 2024)
Net Profit:
8 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-31.72%
0%
-31.72%
1 Year
26.76%
0%
26.76%
2 Years
56.36%
0%
56.36%
3 Years
-31.59%
0%
-31.59%
4 Years
-61.25%
0.18%
-61.07%
5 Years
-1.03%
1.99%
0.96%

Latest dividend: 3 per share ex-dividend date: Aug-18-2021

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-1.46%
EBIT Growth (5y)
-17.14%
EBIT to Interest (avg)
0.47
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.64
Tax Ratio
54.13%
Dividend Payout Ratio
0
Pledged Shares
40.74%
Institutional Holding
17.86%
ROCE (avg)
2.42%
ROE (avg)
4.58%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
1.63
EV to EBIT
36.88
EV to EBITDA
15.23
EV to Capital Employed
1.35
EV to Sales
1.98
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.83%
ROE (Latest)
-32.34%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

40.7357

Mutual Funds

Held by 3 Schemes (1.28%)

FIIs

Held by 62 FIIs (14.67%)

Promoter with highest holding

Devicam Capital Llp (15.53%)

Highest Public shareholder

Spiracca Ventures Llp . (7.78%)

Individual Investors Holdings

21.92%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -13.44% vs -4.55% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 1.00% vs 159.51% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "300.31",
          "val2": "346.95",
          "chgp": "-13.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "57.68",
          "val2": "61.31",
          "chgp": "-5.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "26.54",
          "val2": "28.28",
          "chgp": "-6.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8.09",
          "val2": "8.01",
          "chgp": "1.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.21%",
          "val2": "17.67%",
          "chgp": "1.54%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -8.63% vs 16.32% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 85.15% vs -39.11% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "710.44",
          "val2": "777.55",
          "chgp": "-8.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "103.23",
          "val2": "56.75",
          "chgp": "81.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "59.15",
          "val2": "49.05",
          "chgp": "20.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-5.22",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.45",
          "val2": "-36.71",
          "chgp": "85.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.53%",
          "val2": "7.30%",
          "chgp": "7.23%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -1.51% vs -3.47% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 100.85% vs -1,102.97% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,010.75",
          "val2": "1,026.28",
          "chgp": "-1.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "160.91",
          "val2": "-104.94",
          "chgp": "253.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "85.69",
          "val2": "74.42",
          "chgp": "15.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-67.99",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.64",
          "val2": "-312.05",
          "chgp": "100.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.92%",
          "val2": "-10.23%",
          "chgp": "26.15%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -10.73% vs 13.83% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -2,459.27% vs 61.87% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,288.92",
          "val2": "1,443.81",
          "chgp": "-10.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-95.18",
          "val2": "133.89",
          "chgp": "-171.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "105.11",
          "val2": "90.06",
          "chgp": "16.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-190.17",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-567.39",
          "val2": "-22.17",
          "chgp": "-2,459.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-7.38%",
          "val2": "9.27%",
          "chgp": "-16.65%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
300.31
346.95
-13.44%
Operating Profit (PBDIT) excl Other Income
57.68
61.31
-5.92%
Interest
26.54
28.28
-6.15%
Exceptional Items
0.00
0.00
Consolidate Net Profit
8.09
8.01
1.00%
Operating Profit Margin (Excl OI)
19.21%
17.67%
1.54%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -13.44% vs -4.55% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 1.00% vs 159.51% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
710.44
777.55
-8.63%
Operating Profit (PBDIT) excl Other Income
103.23
56.75
81.90%
Interest
59.15
49.05
20.59%
Exceptional Items
0.00
-5.22
100.00%
Consolidate Net Profit
-5.45
-36.71
85.15%
Operating Profit Margin (Excl OI)
14.53%
7.30%
7.23%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -8.63% vs 16.32% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 85.15% vs -39.11% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,010.75
1,026.28
-1.51%
Operating Profit (PBDIT) excl Other Income
160.91
-104.94
253.34%
Interest
85.69
74.42
15.14%
Exceptional Items
0.00
-67.99
100.00%
Consolidate Net Profit
2.64
-312.05
100.85%
Operating Profit Margin (Excl OI)
15.92%
-10.23%
26.15%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -1.51% vs -3.47% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 100.85% vs -1,102.97% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,288.92
1,443.81
-10.73%
Operating Profit (PBDIT) excl Other Income
-95.18
133.89
-171.09%
Interest
105.11
90.06
16.71%
Exceptional Items
-190.17
0.00
Consolidate Net Profit
-567.39
-22.17
-2,459.27%
Operating Profit Margin (Excl OI)
-7.38%
9.27%
-16.65%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -10.73% vs 13.83% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -2,459.27% vs 61.87% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Solara Active Pharma Sciences Ltd stock-summary
stock-summary
Solara Active Pharma Sciences Ltd
Small Cap
Pharmaceuticals & Drugs
Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs). The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru.
Company Coordinates stock-summary
Company Details
201 Devavrata Sector 17 Vashi, Navi Mumbai Mumbai Maharashtra : 400703
stock-summary
Tel: 91-22-27892924
stock-summary
http://www.solara.co.in
stock-summary
investors@solara.co.in
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."